| Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function G Serini, D Valdembri, S Zanivan, G Morterra, C Burkhardt, F Caccavari, ... Nature 424 (6947), 391-397, 2003 | 643 | 2003 |
| The chemokine system in cancer biology and therapy A Mantovani, B Savino, M Locati, L Zammataro, P Allavena, R Bonecchi Cytokine & growth factor reviews 21 (1), 27-39, 2010 | 436 | 2010 |
| Differential regulation of iron homeostasis during human macrophage polarized activation S Recalcati, M Locati, A Marini, P Santambrogio, F Zaninotto, M De Pizzol, ... European journal of immunology 40 (3), 824-835, 2010 | 405 | 2010 |
| Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility G Solinas, S Schiarea, M Liguori, M Fabbri, S Pesce, L Zammataro, ... The Journal of Immunology 185 (1), 642-652, 2010 | 399 | 2010 |
| Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology OM Pello, M De Pizzol, M Mirolo, L Soucek, L Zammataro, A Amabile, ... Blood, The Journal of the American Society of Hematology 119 (2), 411-421, 2012 | 333 | 2012 |
| Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2 S Mitola, C Ravelli, E Moroni, V Salvi, D Leali, K Ballmer-Hofer, ... Blood, The Journal of the American Society of Hematology 116 (18), 3677-3680, 2010 | 210 | 2010 |
| Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ... Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016 | 168 | 2016 |
| Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis MM Mitchell, A Lleo, L Zammataro, MJ Mayo, P Invernizzi, N Bach, ... Epigenetics 6 (1), 95-102, 2011 | 81 | 2011 |
| Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase–dependent mechanism 1 S Mitola, B Brenchio, M Piccinini, L Tertoolen, L Zammataro, G Breier, ... Circulation research 98 (1), 45-54, 2006 | 72 | 2006 |
| RANK‐dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations A Pangrazio, B Cassani, MM Guerrini, JC Crockett, V Marrella, ... Journal of Bone and Mineral Research 27 (2), 342-351, 2012 | 70 | 2012 |
| Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis C Selmi, F Cavaciocchi, A Lleo, C Cheroni, R De Francesco, SA Lombardi, ... Frontiers in immunology 5, 128, 2014 | 65 | 2014 |
| NOTCH3 expression is linked to breast cancer seeding and distant metastasis AA Leontovich, M Jalalirad, JL Salisbury, L Mills, C Haddox, M Schroeder, ... Breast Cancer Research 20 (1), 1-19, 2018 | 60 | 2018 |
| X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma C Selmi, CA Feghali-Bostwick, A Lleo, SA Lombardi, M De Santis, ... Clinical & Experimental Immunology 169 (3), 253-262, 2012 | 59 | 2012 |
| Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro S Bellone, E Bignotti, S Lonardi, F Ferrari, F Centritto, A Masserdotti, ... Gynecologic oncology 144 (1), 146-152, 2017 | 58 | 2017 |
| A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma C Han, S Bellone, ER Siegel, G Altwerger, G Menderes, E Bonazzoli, ... Gynecologic oncology 149 (3), 585-591, 2018 | 55 | 2018 |
| Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy L Zammataro, S Lopez, S Bellone, F Pettinella, E Bonazzoli, E Perrone, ... Proceedings of the National Academy of Sciences 116 (45), 22730-22736, 2019 | 53 | 2019 |
| Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors C Li, E Bonazzoli, S Bellone, J Choi, W Dong, G Menderes, G Altwerger, ... Proceedings of the National Academy of Sciences 116 (2), 619-624, 2019 | 48 | 2019 |
| Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic RearrangementRegression of CD274 … S Bellone, N Buza, J Choi, L Zammataro, L Gay, J Elvin, DL Rimm, Y Liu, ... Clinical Cancer Research 24 (14), 3282-3291, 2018 | 47 | 2018 |
| SYD985, a novel duocarmycin-based HER2-targeting antibody–drug conjugate, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/Neu expression G Menderes, E Bonazzoli, S Bellone, J Black, F Predolini, F Pettinella, ... Clinical Cancer Research 23 (19), 5836-5845, 2017 | 46 | 2017 |
| Integrated mutational landscape analysis of uterine leiomyosarcomas J Choi, A Manzano, W Dong, S Bellone, E Bonazzoli, L Zammataro, X Yao, ... Proceedings of the National Academy of Sciences 118 (15), e2025182118, 2021 | 40 | 2021 |
